top of page

$1.5M SBIR Phase II Awarded for Nanobind Development

Circulomics has been awarded a $1.5M Phase II SBIR grant by the National Institutes of Health (NIH) - National Institute of General Medical Sciences (NIGMS) to create a comprehensive DNA and RNA extraction product portfolio based on the Nanobind technology first developed in Phase I.

A press release has been issued with additional details. Circulomics receives coverage on GenomeWeb.

Featured Posts

NIH Awards $1.5M SBIR Phase II Grant to Build PicoSep System to Analyze Nucleic Acid Sample Quality

NIH Awards $1.5M SBIR Phase II Grant to Build PicoSep System to Analyze Nucleic Acid Sample Quality

Nanobind DNA Extraction Featured on Back Cover of Advanced Materials

Nanobind DNA Extraction Featured on Back Cover of Advanced Materials

Recent Posts

High Molecular Weight DNA Extraction from Recalcitrant Plant Species for Third Generation Sequencing

Circulomics Publishes New Technology for DNA Concentration

Circulomics Awarded $1.7M in SBIR Grants to Develop Nanobind Methods for FFPE and NGS Sample Prepara

Journal Article Details the Use of Ligo-miR EZ for Quantifying miRNA Copy Number

Circulomics Joins Harbor Launch at IMET

"Other states are using Maryland as a farm team for their biotech clusters."

NIH Awards $1.5M SBIR Phase II Grant to Build PicoSep System to Analyze Nucleic Acid Sample Quality

Nanobind DNA Extraction Featured on Back Cover of Advanced Materials

The Circulomics Trademark Has Officially Been Registered!

PicoSep Can Be Used to Determine Single Molecule DNA Conformation

Archive

Search By Tags

Follow Us

bottom of page